The CLN Focus on Mass Spectrometry is supported by Waters Corporation

Similar documents
ASEAN GUIDELINES FOR VALIDATION OF ANALYTICAL PROCEDURES

Draft Guideline on Bioanalytical Method (Ligand Binding Assay) Validation in Pharmaceutical Development. (24 January, 2014, MHLW, Japan)

Perfluorinated Alkyl Acids (PFAA) in Water by LC/MS/MS - PBM

Quality Assurance is what we do to get the right answer for our purpose FITNESS FOR PURPOSE

ALLOWAY METHOD OUTLINE

OF ANALYSIS FOR DETERMINATION OF PESTICIDES RESIDUES IN FOOD (CX/PR 15/47/10) European Union Competence European Union Vote

VALIDATION OF A UPLC METHOD FOR A BENZOCAINE, BUTAMBEN, AND TETRACAINE HYDROCHLORIDE TOPICAL SOLUTION

APPENDIX II QUALITY CONTROL SUMMARY TABLES

Uncontrolled Copy. Table of Contents. 1. Principle of Assay Specimens Reagents and Materials... 3

LAP-013. Procedure Title: Date: 6/28/96. Author: Raymond Ruiz and Tina Ehrman ISSUE DATE: 8/26/96 SUPERSEDES: 11/01/94.

SUPPORTING INFORMATION

Analytical Measurement Uncertainty APHL Quality Management System (QMS) Competency Guidelines

High-Throughput LC-MS/MS Quantification of Estrone (E1) and Estradiol (E2) in Human Blood Plasma/Serum for Clinical Research Purposes

The Theory of HPLC. Quantitative and Qualitative HPLC

Appendix II- Bioanalytical Method Development and Validation

Understanding the Uncertainty Associated with Analytical Results: Sources, Control and Interpretation of Results. Marc Paquet, Chemist M.Sc.

Draft Guideline on Bioanalytical Method Validation in. Pharmaceutical Development. (15 April 2013, MHLW, Japan)

Copyright ENCO Laboratories, Inc. II. Quality Control. A. Introduction

VAM Project Development and Harmonisation of Measurement Uncertainty Principles

Validation of analytical methods. Adrian Covaci Toxicological Center, University of Antwerp

Measurement Uncertainty: A practical guide to understanding what your results really mean.

serve the goal of analytical lmethod Its data reveals the quality, reliability and consistency of

COLA Mass Spec Criteria

Uncontrolled Copy. Table of Contents. 1. Introduction and Principle of Assay Specimens Reagents and Materials...

Chem 155 Unit 1 Spring 2010 Page 1 of 5

Uncertainty of Measurement

SUGGESTED PROCEDURES FOR

Analysis of Serum 17-Hydroxyprogesterone, Androstenedione, and Cortisol by UPLC-MS/MS for Clinical Research

7. Stability indicating analytical method development and validation of Ramipril and Amlodipine in capsule dosage form by HPLC.

DETERMINATION OF DRUG RELEASE DURING DISSOLUTION OF NICORANDIL IN TABLET DOSAGE FORM BY USING REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY

3.1.1 The method can detect, identify, and potentially measure the amount of (quantify) an analyte(s):

Hydride Generation for the Determination of As, Sb, Se and Bi Using the Teledyne Leeman Lab s Prodigy 7 ICP-OES

Revision: 11 (MBAS) ALLOWAY METHOD OUTLINE. Standard Laboratory Method:

Validation of TNCO, TSNAs, and PAHs

Signal, Noise, and Detection Limits in Mass Spectrometry

This procedure describes the monitoring activities in a laboratory quality control (QC) program to ensure the quality of test results.

An Investigation of Separable Organics for the Hanford Tank Waste Pre-Treatment

EPA Method 535: Detection of Degradates of Chloroacetanilides and other Acetamide Herbicides in Water by LC/MS/MS

LAMBTON SCIENTIFIC (A Division of Technical Chemical Services Inc.)

1,2-Dibromoethane (EDB) and 1,2-dibromo-3-chloropropane (DBCP), gas chromatography, microextraction

GUIDELINES ON PERFORMANCE CRITERIA FOR METHODS OF ANALYSIS FOR THE DETERMINATION OF PESTICIDE RESIDUES IN FOOD AND FEED CXG Adopted in 2017.

Laboratory ID. Laboratory Name. Analyst(s) Auditor. Date(s) of Audit. Type of Audit Initial Biennial Special ELCP TNI/NELAP.

EPA Method 535: Detection of Degradates of Chloroacetanilides and other Acetamide Herbicides in Water by LC/MS/MS

Appendix A - Test Methods Method 301--Field Validation of Pollutant Measurement Methods from Various Waste Media

Assay Transfer from HPLC to UPLC for Higher Analysis Throughput

PROCEDURES. Pharmacopeial Forum 2 Vol. 36(1) [Jan. Feb. 2009]

BIOANALYTICAL METHOD VALIDATION M10

Validation Report Determination of isoprothiolane residues in rice by GC-MS/MS (QuEChERS method)

GRANT AGREEMENT # Safe-T. Safer and Faster Evidenced-Based Translation

OBJECTIVE DATA PACKAGE DELIVERABLES

A Discussion of Measurement of Uncertainty for Life Science Laboratories

Quantitative analysis of small molecules in biological samples. Jeevan Prasain, Ph.D. Department of Pharmacology & Toxicology, UAB.

á233ñ ELEMENTAL IMPURITIES PROCEDURES

STANDARD OPERATING PROCEDURES SOP: 1826 PAGE: 1 of 18 REV: 0.0 DATE: 03/30/95 ANALYSIS OF METHYL PARATHION IN WIPE SAMPLES BY GC/MS

Analytical Performance & Method. Validation

A Statistical Method to Demonstrate DilutionalLinearity for Immunoassays

Gas Chromatography Mass Spectrometry (GCMS)

The Use of the ACQUITY QDa Detector for a Selective, Sensitive, and Robust Quantitative Method for a Potential Genotoxic Impurity

Total Organic Carbon Analysis of Solid Samples for Environmental and Quality Control Applications

Analytical Method Validation: An Updated Review

And how to do them. Denise L Seman City of Youngstown

The Analysis of Fluoroquinolones in Beef Kidney Using HPLC Electrospray Mass Spectrometry Application

Review and Reporting of Chemical of Concern (COC) Concentration Data Under the TRRP Rule (30 TAC 350)

International Journal of Pharma and Bio Sciences

Application of mathematical, statistical, graphical or symbolic methods to maximize chemical information.

Appendix A. Glossary of Definitions, Acronyms, Abbreviations and Symbols. March 1997

Application Note for Gentian Cystatin C Immunoassay on. Cobas c501 1 (Optimised Volumes II), Roche Diagnostics 1 v06-september 2010

2. Reagent Store at 2-8ºC. 3. Standard - - Calcium 10 mg/dl - Store at 2-30ºC. CALCIUM Liquiform Insert. 01 English - Ref.: 90. Ref.

ELISA QUALITY ASSURANCE Analytical Phase

Pharmacopeial Forum Vol. 36(1) [Jan. Feb. 2010] 1

Background on Solubility

LC-MS/MS Method for the Determination of Diclofenac in Human Plasma

Human Creatinine Serum Detection Kit

Chapter 4: Verification of compendial methods

Data Glossary. Acceptance criteria - specific limits placed on characteristics of an item, process, or service defined in requirements documents.

Impact factor: 3.958/ICV: 4.10 ISSN:

METHOD 7196A CHROMIUM, HEXAVALENT (COLORIMETRIC)

Package Insert for FASafe/AciSafe

Method Validation. Role of Validation. Two levels. Flow of method validation. Method selection

CHEM 3420 /7420G Instrumental Analysis

Validation Report 18

Qualification Code Reference Table Cont.

QUALITY CONTROL CRITERIA FOR CHEMISTRY EXCEPT RADIOCHEMISTRY.

Fast Screening and Quantitation of Perfluorinated Sources from Textiles using Chemical Ionization GC-MS

Rapid and Accurate Forensics Analysis using High Resolution All Ions MS/MS

Laboratory Techniques 100: Back To Basics. Carol Injasoulian Lab Manager City of Bay City April 29,2015

01 English - Ref.: 95. Intended use. End point reaction system for determination of calcium in blood and urine.

Is the laboratory s pledge or declaration of the quality of the results produced. to produce data compliant with the Safe Drinking Water Act (SDWA)

Validation and Standardization of (Bio)Analytical Methods

TEMPLATE FOR AN EXAMPLE STANDARD TEST METHOD

LC-MS/MS in the Clinical Laboratory. Jo Adaway

Proposed Procedures for Determining the Method Detection Limit and Minimum Level

DRI Ecstasy Assay Application BECKMAN COULTER UniCel DxC and Synchron System(s)

OPTIMIZING METALS SAMPLE PREP

Laboratory Quality Control Report: Why is it Important?

A validated flame AAS method for determining magnesium in a multivitamin pharmaceutical preparation

CCME Reference Method for the Canada-Wide Standard for Petroleum Hydrocarbons (PHC) in Soil - Tier 1 Method

Clinical performance of Swelab Lumi 5-part hematology analyzer

462 1 & (2&3 ( 4 5 6" 6 7 ' ("0 / L1 1 % FG &

Precision estimated by series of analysis ISO and Approach Duplicate Approach

Transcription:

Clinical Laboratory News An AACC Publication August, 07 The CLN Focus on Mass Spectrometry is supported by Waters Corporation Matrix Experimental For Exogenous Analytes Collect six individual, drug free, native matrix samples Prepare to spike low and high concentration test samples for each of the six drug free native matrix samples using the standard sample preparation procedure in replicates of three; label tubes for low and tubes for high concentration aliquots for each test sample (n=; 8 low and 8 high concentration samples) Prepare low and high concentration control samples (substituting an equivalent volume of water or solvent mixture, dependent on analyte solubility for native matrix) in replicates of three (consider the final volume to allow reinjection for comparison with test samples). samples are prepared using the standard sample preparation procedure; label tubes for low and tubes for high concentration aliquots for each control sample (n=; low and high concentration samples). These samples are used as the reference i.e. there should be no ion suppression or enhancement since no residual native matrix is present. Following sample preparation, test and control samples are spiked with anaylte(s) at two concentrations (low and high). Samples may be spiked using a low volume of solution containing analyte(s) or a small volume of the final preparation is removed (typically %) and the same volume of a solution containing analyte(s) added. Prepare singlicate calibrators and duplicate quality control samples using the standard sample preparation procedure Analyze the prepared samples following the test order described: Calibrators, quality control set, solvent blank, low concentration test sample, low concentration control sample, low concentration test sample, low concentration control sample, low concentration test sample, low concentration control sample, high concentration test sample, high concentration control sample, high concentration test sample, high concentration control sample, high concentration test sample, high concentration control sample. quality control set

Process the data, establish that the calibration line and quality control samples meet acceptance criteria and determine analyte peak areas and internal standard peak areas for test and control samples Calculate the mean peak area, SD and %CV for test samples for each analyte Calculate the mean peak area, SD and %CV for control samples for each analyte Calculate the percent matrix effect for each analyte using the following equation: peakarea intest samples x00 peakarea incontrolsamples Calculate the mean response for each analyte using the following equation: Analytepeakarea Internalstandardpeakarea Additionally, calculate the normalized (internal standard adjusted) percent matrix effect for each analyte using the following equation: response intest samples % NormalizedMatrix x00 response incontrolsamples The percent matrix effect is a quantitative measure of how much the matrix influences response - Values <00% indicate suppression - Values >00% indicate enhancement Percent matrix effect may differ between the six matrices tested, the response %CV provides a measure of variability and should be less than % (as stated in CLSI Guideline C-A) Calculation of the normalized percent matrix effect should give confidence that the internal standard is compensating for matrix effects in the sample by giving a matrix effect value of close to 00%

Percent Matrix Example Calculations Analyte No internal standard adjustment, low concentration: Peak Area 00 8 99 9 07 9 7 7 0 00 97 9.7.9 00 99 9 00 9 08 8 7 0 0 Percent Matrix = 99% (n=, range 9-0%).

No internal standard adjustment, high concentration: Peak Area 990 80 88 77 97 90 80 009 9 08 879 907.9 90 99 0.7 890 97 8 897 99 99 07 79 987 77 8 98 7 08 Percent Matrix = 08% (n=, range 99-%)

Internal standard adjustment, low concentration: 0.088 0.09 0.08 99 0.08 0.0879 0.08 0.0900 0.088 0.089 0.0888 0 0.088 0.088 97 0.088 0.089. 0.0879 0.087. 0.088 0.0870 0.087 0.08 99 0.088 0.087 00 0.0907 0.087 0.087 0.08 0.08 0.088 98 Percent Normalized Matrix = 99% (n=, range 98-0%)

Internal standard adjustment, high concentration:..9.7 97...8.... 9.. 98.8.8.8.79...9..80.9 99..9 99..0.70... 00 Percent Normalized Matrix = 98% (n=, range 9-00%) In this example, there is little suggestion of a matrix effect, even without considering the internal standard, as matrix factors are in the region of 90-0%. Using internal standard adjusted matrix factor gives results close to 00%.

Analyte No internal standard adjustment, low concentration: Peak Area 09 07 07 9 0 0 9 0 00 00 0 9 88 0..9 9 99 0 0 9 08 09 07 9 08 9 Percent Matrix = % (n=, range -9%)

No internal standard adjustment, high concentration: Peak Area 7 79 7 8 77 07 70 77 9 9 7 70 0 8 8 08 0. 7 989. 9 8 80 7 8 79 0 9 8 9 9 Percent Matrix Factor = % (n=, range -7%)

Internal standard adjustment, low concentration: 0.0 0.00 0.08 97 0.009 0.0 0.00 0.00 0.00 0.0 0.08 97 0.0 0.0 9 0.08 0.0 7.0 0.0 0.09. 0.0 0.077 0.009 0.009 9 0.0 0.0 9 0.078 0.0 0.08 0.0 0.0 0.0 98 Percent Normalized Matrix = 9% (n=, range 9-98%)

Internal standard adjustment, high concentration:.0.. 0..7.7.7...9 0..9 0.7..7....... 00.0. 0.09.7..8.0. 9 Percent Normalized Matrix = 0% (n=, range 9-0%) In this example there is evidence of ion suppression, as the unadjusted matrix effects are well below 00%. However, using internal standard adjusted matrix effects gives results close to 00%.